Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial

被引：0
|
作者：
Jan J. De Waele
S. Carrette
M. Carlier
V. Stove
J. Boelens
G. Claeys
I. Leroux-Roels
E. Hoste
P. Depuydt
J. Decruyenaere
A. G. Verstraete
机构：
[1] Ghent University Hospital,Department of Critical Care Medicine
[2] Ghent University Hospital,Department of Clinical Chemistry, Microbiology and Immunology
来源：
Intensive Care Medicine | 2014年 / 40卷
关键词：
β-Lactam antibiotics; Pharmacokinetics; Pharmacodynamics; Therapeutic drug monitoring; Critical care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：380 / 387
页数：7
相关论文
共 50 条
  • [1] Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial
    De Waele, Jan J.
    Carrette, S.
    Carlier, M.
    Stove, V.
    Boelens, J.
    Claeys, G.
    Leroux-Roels, I.
    Hoste, E.
    Depuydt, P.
    Decruyenaere, J.
    Verstraete, A. G.
    INTENSIVE CARE MEDICINE, 2014, 40 (03) : 380 - 387
  • [2] Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial
    Stefan Hagel
    Sandra Fiedler
    Andreas Hohn
    Alexander Brinkmann
    Otto R. Frey
    Heike Hoyer
    Peter Schlattmann
    Michael Kiehntopf
    Jason A. Roberts
    Mathias W. Pletz
    Trials, 20
  • [3] Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial
    Hagel, Stefan
    Fiedler, Sandra
    Hohn, Andreas
    Brinkmann, Alexander
    Frey, Otto R.
    Hoyer, Heike
    Schlattmann, Peter
    Kiehntopf, Michael
    Roberts, Jason A.
    Pletz, Mathias W.
    Bloos, Frank
    Angermair, Stefan
    Bracht, Hendrik
    Barth, Eberhard
    Kluge, Stefan
    Nierhaus, Axel
    Motsch, Johann
    Brenner, Thorsten
    Annecke, Thorsten
    Bach, Friedhelm
    Weigand, Markus
    Schappacher, Markus
    von Ameln-Mayerhofer, Andreas
    Michels, Guido
    Roehr, Anka
    Fuchs, Thomas
    Eichner, Sarah
    Barth, Eberhard
    Kong, Christina
    Pinder, Nadine
    Mueller, Carsten
    Petersen, Miriam
    Schlattmann, Peter
    Steinbach, Gerald
    Jarczak, Dominik
    Weisman, Dirk
    Kurlbaum, Max
    Braune, Anke
    TRIALS, 2019, 20 (1)
  • [4] Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
    Stefan Hagel
    Friedhelm Bach
    Thorsten Brenner
    Hendrik Bracht
    Alexander Brinkmann
    Thorsten Annecke
    Andreas Hohn
    Markus Weigand
    Guido Michels
    Stefan Kluge
    Axel Nierhaus
    Dominik Jarczak
    Christina König
    Dirk Weismann
    Otto Frey
    Dominic Witzke
    Carsten Müller
    Michael Bauer
    Michael Kiehntopf
    Sophie Neugebauer
    Thomas Lehmann
    Jason A. Roberts
    Mathias W. Pletz
    Intensive Care Medicine, 2022, 48 : 311 - 321
  • [5] Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
    Hagel, Stefan
    Bach, Friedhelm
    Brenner, Thorsten
    Bracht, Hendrik
    Brinkmann, Alexander
    Annecke, Thorsten
    Hohn, Andreas
    Weigand, Markus
    Michels, Guido
    Kluge, Stefan
    Nierhaus, Axel
    Jarczak, Dominik
    Koenig, Christina
    Weismann, Dirk
    Frey, Otto
    Witzke, Dominic
    Mueller, Carsten
    Bauer, Michael
    Kiehntopf, Michael
    Neugebauer, Sophie
    Lehmann, Thomas
    Roberts, Jason A.
    Pletz, Mathias W.
    Investigators, The Target Trial
    INTENSIVE CARE MEDICINE, 2022, 48 (03) : 311 - 321
  • [6] Dose Optimisation of Posaconazole and Therapeutic Drug Monitoring in Pediatric Patients
    Jia, Mengmeng
    Zhang, Qiwen
    Qin, Zifei
    Wang, Dao
    Liu, Peng
    Yang, Jing
    Zhang, Xiaojian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population-A prospective, multi-center, observational study (BLAST 1)
    Chua, Nathalie Grace
    Loo, Liwen
    Hee, Daryl Kim Hor
    Lim, Tze Peng
    Ng, Tat Ming
    Hoo, Grace Si Ru
    Soong, Jie Lin
    Ong, Jasmine Chiat Ling
    Tang, Sarah Si Lin
    Zhou, Yvonne Peijun
    Lee, Winnie
    Lee, Lawrence Soon-U
    Cove, Matthew
    Ling, Li Min
    Kwa, Andrea Layhoon
    JOURNAL OF CRITICAL CARE, 2022, 68 : 107 - 113
  • [8] Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial
    Sime, Fekade Bruck
    Roberts, Michael S.
    Tiong, Ing Soo
    Gardner, Julia H.
    Lehman, Sheila
    Peake, Sandra L.
    Hahn, Uwe
    Warner, Morgyn S.
    Roberts, Jason A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (08) : 2369 - 2375
  • [9] Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients
    Schoenenberger-Arnaiz, Joan Antoni
    Ahmad-Diaz, Faten
    Miralbes-Torner, Mar
    Aragones-Eroles, Ana
    Cano-Marron, Manuel
    Palomar-Martinez, Mercedes
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (E1) : E30 - E35
  • [10] Population PK/PD modelling of meropenem in preterm newborns based on therapeutic drug monitoring data
    Zyryanov, Sergey
    Bondareva, Irina
    Butranova, Olga
    Kazanova, Alexandra
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345